| Product Code: ETC9940000 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Cancer Therapy Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Cancer Therapy Market - Industry Life Cycle |
3.4 United Kingdom (UK) Cancer Therapy Market - Porter's Five Forces |
3.5 United Kingdom (UK) Cancer Therapy Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 United Kingdom (UK) Cancer Therapy Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 United Kingdom (UK) Cancer Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Cancer Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the United Kingdom |
4.2.2 Advances in cancer research and development of innovative therapies |
4.2.3 Growing adoption of personalized medicine in cancer treatment |
4.3 Market Restraints |
4.3.1 High cost associated with cancer therapy |
4.3.2 Stringent regulatory requirements for drug approval |
4.3.3 Limited access to specialized cancer care facilities in certain regions |
5 United Kingdom (UK) Cancer Therapy Market Trends |
6 United Kingdom (UK) Cancer Therapy Market, By Types |
6.1 United Kingdom (UK) Cancer Therapy Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Target Therapy, 2021- 2031F |
6.1.5 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.6 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.1.7 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Other Treatment Types, 2021- 2031F |
6.2 United Kingdom (UK) Cancer Therapy Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Blood Cancer, 2021- 2031F |
6.2.3 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.4 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.5 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Gastrointestinal Cancer, 2021- 2031F |
6.2.6 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Gynecologic Cancer, 2021- 2031F |
6.2.7 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Respiratory/Lung Cancer, 2021- 2031F |
6.3 United Kingdom (UK) Cancer Therapy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 United Kingdom (UK) Cancer Therapy Market Revenues & Volume, By Cancer and Radiation Therapy Center, 2021- 2031F |
7 United Kingdom (UK) Cancer Therapy Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Cancer Therapy Market Export to Major Countries |
7.2 United Kingdom (UK) Cancer Therapy Market Imports from Major Countries |
8 United Kingdom (UK) Cancer Therapy Market Key Performance Indicators |
8.1 Patient survival rates post-cancer therapy |
8.2 Adoption rate of new cancer therapies in the UK |
8.3 Rate of clinical trial participation for cancer treatments |
9 United Kingdom (UK) Cancer Therapy Market - Opportunity Assessment |
9.1 United Kingdom (UK) Cancer Therapy Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 United Kingdom (UK) Cancer Therapy Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 United Kingdom (UK) Cancer Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Cancer Therapy Market - Competitive Landscape |
10.1 United Kingdom (UK) Cancer Therapy Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Cancer Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here